Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Outlook Therapeutics (OTLK)
Technical Analysis Report for USA stock OTLK Outlook Therapeutics. Dated: 08 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock OTLK Outlook Therapeutics then click here. or read Experts views on Outlook Therapeutics or Forecast & share price targets of Outlook Therapeutics
Outlook Therapeutics Opened at 0.58 and Closed at: 0.61, which is 3.28% of previous session's close. It moved within a range of 0.56 and 0.65
The session was a Bullish session with an average volume of 6025555, which is -152.81% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
A Dead cross was found 7 days back on short term averages
A Dead cross was found 4 days back on mid term averages
Support for tomorrow is 0.59 and resistance for tomorrow is 0.68
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.56, 0.52 resistance for tomorrow's hourly charts is 0.65, 0.7
10 Day SMA for Outlook Therapeutics (OTLK) is 1.2 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Outlook Therapeutics (OTLK) is 1.64 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Outlook Therapeutics (OTLK) is 1.62 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.47 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Outlook Therapeutics is 1.6 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Outlook Therapeutics is at 1.64 and 200 DMA is at 1.6, while 50 DMA and 100 DMA are at 1.62 and 1.47 respectively
Outlook Therapeutics (OTLK) moving average of 20 SMA is at 1.64 and 20 EMA is at 1.38
| Date | Closing Price | 20 SMA | 20 EMA |
| 08 Thu Jan | 0.61 | 1.64 | 1.38 |
| 07 Wed Jan | 0.59 | 1.71 | 1.46 |
| 06 Tue Jan | 0.54 | 1.78 | 1.55 |
| 05 Mon Jan | 0.54 | 1.86 | 1.66 |
| 02 Fri Jan | 0.66 | 1.93 | 1.78 |
| 31 Wed Dec | 1.59 | 2 | 1.9 |
Outlook Therapeutics (OTLK) moving average of 50 SMA is at 1.62 and 50 EMA is at 1.53
| Date | Closing Price | 50 SMA | 50 EMA |
| 08 Thu Jan | 0.61 | 1.62 | 1.53 |
| 07 Wed Jan | 0.59 | 1.63 | 1.57 |
| 06 Tue Jan | 0.54 | 1.65 | 1.61 |
| 05 Mon Jan | 0.54 | 1.66 | 1.65 |
| 02 Fri Jan | 0.66 | 1.68 | 1.7 |
| 31 Wed Dec | 1.59 | 1.7 | 1.74 |
Outlook Therapeutics (OTLK) moving average of 100 SMA is at 1.47 and 100 EMA is at 1.62
| Date | Closing Price | 100 SMA | 100 EMA |
| 08 Thu Jan | 0.61 | 1.47 | 1.62 |
| 07 Wed Jan | 0.59 | 1.49 | 1.64 |
| 06 Tue Jan | 0.54 | 1.51 | 1.66 |
| 05 Mon Jan | 0.54 | 1.53 | 1.68 |
| 02 Fri Jan | 0.66 | 1.54 | 1.7 |
| 31 Wed Dec | 1.59 | 1.56 | 1.72 |
Outlook Therapeutics (OTLK) moving average of 200 SMA is at 1.6 and 200 EMA is at 2.02
| Date | Closing Price | 200 SMA | 200 EMA |
| 08 Thu Jan | 0.61 | 1.6 | 2.02 |
| 07 Wed Jan | 0.59 | 1.6 | 2.03 |
| 06 Tue Jan | 0.54 | 1.61 | 2.04 |
| 05 Mon Jan | 0.54 | 1.61 | 2.06 |
| 02 Fri Jan | 0.66 | 1.62 | 2.08 |
| 31 Wed Dec | 1.59 | 1.62 | 2.09 |
Teleflex Incorporated has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Teleflex Incorporated, about 55.11% more returns!
Arcus Biosciences has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Arcus Biosciences, about 54.87% more returns!
Novo Nordisk has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Novo Nordisk, about 87.75% more returns!
Cardinal Health has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Cardinal Health, about 72.97% more returns!
Urogen Pharma has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Urogen Pharma, about 76.58% more returns!
Neuronetics Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Neuronetics Inc, about 118.18% more returns!
Riot Blockchain has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Riot Blockchain, about 67.98% more returns!
Rigel Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Rigel Pharmaceuticals, about 78.91% more returns!
Medpace Holdings has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Medpace Holdings, about 77.81% more returns!
Moleculin Biotech has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Moleculin Biotech, about 55.9% more returns!
Lifevantage Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Lifevantage Corporation, about 66.15% more returns!
Icon Plc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Icon Plc, about 72.08% more returns!
Hutchison China has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Hutchison China, about 77.99% more returns!
Exelixis Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Exelixis Inc, about 78.31% more returns!
Caredx Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Caredx Inc, about 58.89% more returns!
Bioxcel Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Bioxcel Therapeutics, about 62.13% more returns!
Ardelyx Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Ardelyx Inc, about 88.88% more returns!
Apyx Medical has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Apyx Medical, about 56.67% more returns!
Aclaris Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Aclaris Therapeutics, about 52.77% more returns!
Outlook Therapeutics Technical analysis of indicators
Price action analysis of Outlook Therapeutics (OTLK) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Outlook Therapeutics in short term and the sell signal is strong.
Outlook Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Outlook Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.78 and Outlook Therapeutics OTLK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics OTLK stock. Volume based technical analysis of Outlook Therapeutics OTLK stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock OTLK Outlook Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And OTLK Experts View which covers a lot of information including buying and selling signals
OTLK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Outlook Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


